As many as 60% of Americans support cannabis legalization, with just half opposing it, a new YouGov survey showed. The poll was conducted online on April 25 – 28, 2024, prior to the recent DEA news that it intends to reclassify marijuana as a Schedule III substance.
Removing marijuana from Schedule 1 – the same class as heroin, LSD, meth and ecstasy – to Schedule III along with ketamine, anabolic steroids and testosterone indicates the government's acceptance that the plant has medical value.
The DEA news came on April 30th, which means that the majority of survey participants already had a positive view of marijuana. Results are in line with previous polls that also showed the growing support for cannabis legalization among U.S. residents.
This survey, however, brings more data into the picture – the percentage of those who have used cannabis, their experiences, but also the opinions on three other psychoactive substances that activists have campaigned for legalizing, in part due to their potential therapeutic uses: psilocybin (magic mushrooms), LSD (acid), and MDMA (ecstasy or molly).
As more people come in favor of the plant, more new markets come to life. To learn all about the future of the cannabis industry, join us at the Benzinga Cannabis Capital Conference this October in Chicago. Hear directly from key industry players, advocates, experts, and policymakers. Get your tickets now by following this link.
Key Takeaways
- 75% of adult citizens confirm using cannabis at least once, and 42% more than once.
- 57% of those who tried cannabis, say their experience was mostly positive, 22% attest equally negative and positive experience and 20% say they had a negative impression.
- 20% admit to having tried psilocybin, 16% have used LSD, and just 11% have tried MDMA; About half of people who have used each of these drugs say they’ve used them more than once.
- 27% support legalizing psilocybin, 16% MDMA and only 15% LSD.
- People who have tried each substance are more likely to favor legalizing it than people who haven’t; 78% of marijuana users support its legalization. 63% of psilocybin users want psilocybin legalized, and 55% of MDMA users support MDMA legalization, 38% would support LSD, but 43% oppose LSD legalization.
Photo: Shutterstock
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving – don’t get left behind!
Curious about what’s next for the industry and how to leverage California’s unique market?
Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!
Get your tickets now to secure your spot and avoid last-minute price hikes.